Table 1 |
|
|
Description of baseline patient characteristics |
|
| Characteristics |
Number |
|
|
|
| Gender |
|
| Females |
25 (61%) |
| Males |
16 (39%) |
| Median age (range) |
27 (14–58 years) |
| Smokers (current/ex-smoker) |
14 (34%) |
| Pathology |
|
| Nodular Sclerosing |
39 (95%) |
| Nodular Lymphocyte Predominant |
1 (2%) |
| Mixed Cellularity |
1 (2%) |
| Stage I |
4 (10%) |
| II |
34 (85%) |
| III |
2 (4%) |
| N/A (Relapse) |
1 (2%) |
| Bulky disease * |
28 (72%) |
| Chemotherapy Regimen |
|
| ABVD |
38 (93%) |
| Other |
3 (7%) |
| Median cycles (range) |
4 (3–8) |
| 35 Gy IFRT plan – Treatment Indication |
|
| Adjuvant |
37 |
| Post Transplant |
3 |
| Adjuvant Post-Relapse |
1 |
|
* Bulky disease was defined as ≥ 5 cm on CT scan, and/or a thoracic ratio of maximum transverse mass diameter ≥ 33% of the internal transverse thoracic diameter measured at the T5/6 intervertebral disc level on chest radiography. | |
Koh et al. Radiation Oncology 2007 2:13 doi:10.1186/1748-717X-2-13 |
|
